Navigation Links
EntreMed Secures $5.1 Million in Registered Direct Offering and Enters into Agreement for Rights to License ENMD-2076 in China
Date:9/8/2010

d.  In connection with the financing, the investor group was offered the right to designate one director to EntreMed's Board of Directors, and the director nominee, if selected, will be identified by SVT and submitted to EntreMed for approval and election to the Company's Board of Directors.

The securities described above are being offered through a prospectus supplement and accompanying base prospectus pursuant to a registration statement, previously filed and declared effective by the Securities and Exchange Commission (SEC).  The prospectus supplement related to the offering will be filed with the SEC.  Ferghana Partners acted as financial advisor to EntreMed for these transactions.  Copies of the final prospectus supplement and accompanying base prospectus can be obtained from EntreMed or at the SEC's website at www.sec.gov.

This press release does not and shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities, nor shall there be any sale of the securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any state.

About EntreMedEntreMed, Inc. is a clinical-stage pharmaceutical company committed to developing ENMD-2076, a selective angiogenic kinase inhibitor, for the treatment of cancer.  ENMD-2076 is currently in a multi-center Phase 2 study in ovarian cancer and in several Phase 1 studies in solid tumors, multiple myeloma, and leukemia.  Additional information about EntreMed is available on the Company's web site at www.entremed.com and in various filings with the Securities and Exchange Commission.

Forward Looking StatementsThis release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to the outlook for e
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. EntreMed Receives NASDAQ Listing Rule 5550(b)(2) Determination Letter
2. EntreMed Reports Second Quarter 2010 Financial Results
3. EntreMeds ENMD-2076 Active in Solid and Hematological Cancers
4. Entremed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients
5. EntreMed Presents Initial Clinical Results for ENMD-2076
6. EntreMed Receives New Patent for 2-Methoxyestradiol Analogs
7. EntreMed Presents MKC-1 Phase 2 Data at American Society of Clinical Oncology Annual Meeting
8. EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting
9. EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR Annual Meeting
10. EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
11. EntreMed Commences Continuous Dosing Clinical Trial For MKC-1
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014  Decision Resources Group,s ... about by the Affordable Care Act (ACA), ... of pharmaceutical therapies. The ACA altered how ... new regulations and expanded access via government-supported ... health exchanges—state-based marketplaces set up by states ...
(Date:7/31/2014)... 2014  A substantial share of pharmacy and ... therapies are included in formularies—say patient support resources ... new Manhattan Research study, Taking the Pulse® ... that P&T committee members in hospitals, managed care ... set a high bar for these programs, requiring ...
(Date:7/31/2014)... -- Lazarus Effect, a medical device company focused on ... of blood clots, announced the closing of a $5 ... commercialization of several approved Lazarus Effect devices, as well ... Cover™ in the United States . ... value of our novel, platform technology as well as ...
Breaking Medicine Technology:Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 2Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 4Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 2Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 3Lazarus Effect Closes $5 Million Financing 2
... FRISCO, Texas, March 15, 2012  OxySure® Systems, Inc. ... easy-to-use emergency oxygen solutions with its "oxygen from ... into a Supplier Agreement ("Agreement") with W.W. Grainger, ... (Logo:  http://photos.prnewswire.com/prnh/20120315/DA71084LOGO ) In ...
... According to a national survey of independent pharmacists, ... drugstores and consumers who changed pharmacies. Independent pharmacists say ... ease, and still have many choices despite the absence ... This survey reveals significant upsides to preferred pharmacy ...
Cached Medicine Technology:OxySure Systems Announces Supplier Agreement With Grainger 2OxySure Systems Announces Supplier Agreement With Grainger 3New Survey: Walgreens' Customers Flock to Independent Pharmacies 2
(Date:7/31/2014)... 2014) If you have asthma, you may have an ... you recognize and respond to changes and understand when symptoms ... the green zone, you,re doing well, yellow means your asthma ... require urgent care. New guidelines are now available to help ... into green and away from the red zone. , "Management ...
(Date:7/31/2014)... 31, 2014 Leelanau Peninsula’s newest winery, ... 2014 at 7788 East Horn Road in Lake Leelanau. Joining ... , Aurora Cellars is the 25th winery along the trail. ... popular wine tour events, making its trail event debut during ... , Owners David and Faye Mathia opened the boutique ...
(Date:7/31/2014)... Las Vegas, NV (PRWEB) July 31, 2014 ... personal trainer Tyler Bramlett and physical therapist expert Dr. James ... to shrink waistlines, fix back pain, relieve digestive issues, tone ... abs through a specific sequence of core exercises used to ... , After a quick 0-6 Pack Abs ...
(Date:7/31/2014)... FL (PRWEB) July 31, 2014 ... hospitals in the U.S. including Florida Hospital Tampa, ... Acute Care, Florida Hospital North Pinellas, Florida Hospital ... Medical Center Sebring, Florida Hospital Heartland Medical Center ... & Health Networks list of Most Wired Hospitals ...
(Date:7/31/2014)... Cosmetic Town has introduced a secure verification ... will be able to verify their patients before the ... guarantees their authenticity. This will help prospective patients ... information that has been verified to come from a ... Town to filter out fake patients who leave fraudulent ...
Breaking Medicine News(10 mins):Health News:Aurora Cellars Joins the Leelanau Peninsula Wine Trail 2Health News:Zero To Six Pack Abs System Review Exposes Tyler Bramlett And Dr. James Veghers’ New Ab Training Program 2Health News:Zero To Six Pack Abs System Review Exposes Tyler Bramlett And Dr. James Veghers’ New Ab Training Program 3Health News:Florida Hospital West Florida Region is Among the Most Wired Hospitals and Health Systems in the United States 2Health News:Cosmetic Town Improves Patient Experience Through Secure Verification of Patients and Doctors 2
... UPMC Health Plan announced it has,expanded both its ... its UPMC for Life Specialty Plan into Cameron, ... also announced the,expansion of its Medicare PPO (Preferred ... our footprint in Western Pennsylvania helps us continue ...
... poor physical function, , , TUESDAY, Jan. 22 (HealthDay News) -- If ... have a greater risk of declining physical function as you age, ... researchers report that people with the lowest blood levels of vitamin ... physical function when compared to people with the highest levels of ...
... STERIS Corporation,(NYSE: STE ) today announced that ... in the amount of $0.06 per common share. The,dividend ... at the close,of business on February 12, 2008., ... to provide a healthier today and,safer tomorrow through knowledgeable ...
... International effort should spot genes that help cause disease, ... The genomes of 1,000 people worldwide will be ... and medically relevant look at human genetic variation ever ... researchers on Tuesday, the 1000 Genomes Project will receive ...
... from the Monell Center and Tokyo University of Agriculture ... compounds from common foods that activate human bitter taste ... Biochemical and Biophysical Research Communications, provide a practical means ... in particular. , Identification of bitter taste ...
... nanotechnology, scientists from UCLA and Northwestern University have ... that is invisible to the immune system, a ... treatments for cancer and other diseases. , The ... ACS Nano, provides an example of the enormous ...
Cached Medicine News:Health News:UPMC Health Plan Expands Medicare and Special Needs Plan Into Additional Western Pennsylvania Counties 2Health News:Lack of Vitamin E Linked to Physical Decline 2Health News:Lack of Vitamin E Linked to Physical Decline 3Health News:STERIS Corporation Declares Regular Quarterly Dividend 2Health News:STERIS Corporation Declares Regular Quarterly Dividend 3Health News:Project Will Map Genomes of 1,000 People Worldwide 2Health News:Food peptides activate bitter taste receptors 2Health News:Scientists use nanomaterials to localize and control drug delivery 2Health News:Scientists use nanomaterials to localize and control drug delivery 3
... INVACARE CHECK 02 PLUS CONCENTRATOR ANALYZER ... reports all the operating parameters necessary for ... O2 Plus ™, an efficient and cost-effective ... checks oxygen concentration (%), flow rate (L-min), ...
... the new Platinum 10 concentrator. The Platinum ... advantage you have come to expect from ... an attractive alternative to liquid systems. The ... 10 LPM for high flow patients, and ...
... QuietLife 5 Oxygen Concentrator is a low ... continuous flow oxygen for prescriptions up to ... the quietest running concentrator at <40 dBA, ... or caregivers. Concentrators are also an economical ...
... AirSep's LifeStyle Portable Oxygen Concentrator is ... At less than 10 lbs (4.5 kg), ... traveling, working, and highly active oxygen patient., ... and combining the technologies of both an ...
Medicine Products: